Jonathan Zalevsky
Technik-/Wissenschafts-/F&E-Leiter bei NEKTAR THERAPEUTICS
Vermögen: 340 124 $ am 30.04.2024
Aktive Positionen von Jonathan Zalevsky
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEKTAR THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 | - |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of immune system through PIC1 technology. The company was founded in 2018 and is headquartered in Norfolk, VA. | Direktor/Vorstandsmitglied | - | - |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Direktor/Vorstandsmitglied | 01.11.2021 | - |
| Independent Dir/Board Member | 01.11.2021 | - |
Karriereverlauf von Jonathan Zalevsky
Ehemalige bekannte Positionen von Jonathan Zalevsky
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - | - |
Ausbildung von Jonathan Zalevsky
| University of Colorado Boulder | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of immune system through PIC1 technology. The company was founded in 2018 and is headquartered in Norfolk, VA. | Commercial Services |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Börse
- Insiders
- Jonathan Zalevsky
- Erfahrung
